RedHill Biopharma Announces $1.25M Registered Direct Offering at a Premium to Market Price
RedHill Biopharma Announces $1.25M Registered Direct Offering at a Premium to Market Price
RedHill Biopharma宣佈以高於市價的價格註冊直接發行125萬美元
RedHill Biopharma Announces $1.25M Registered Direct Offering at a Premium to Market Price
RedHill Biopharma宣佈以高於市價的價格註冊直接發行125萬美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。